Charles A. Sanders

Charles A. Sanders, M.D., is the former chairman and CEO of GlaxoSmithKline, Inc., as well as a former member of the board of Glaxo PLC. Before joining Glaxo, Dr. Sanders spent eight years with Squibb Corp., where he held a number of posts, including the position of vice chairman. He also served as CEO of the Science and Technology Group and chairman of the Science and Technology Committee. Previously, Dr. Sanders was general director of Massachusetts General Hospital and professor of medicine at Harvard Medical School. A native of Dallas, Texas, he is a graduate of Southwestern Medical College of the University of Texas. Dr. Sanders is past chairman of the New York Academy of Sciences and the Commonwealth Fund. He is currently a member of the Institute of Medicine of the National Academy of Sciences and chairman of Project HOPE, the Foundation for the National Institutes of Health, and Icagen, Inc. He previously served as the chairman of Vertex Pharmaceuticals, Inc., and is still a member of that board. In addition, Dr. Sanders has served on the boards of Merrill Lynch, Reynolds Metals Co., Morton International, Inc., Fisher Scientific International, and Biopure Corporation. He is also a director of Biodel, Inc.; Cephalon Corporation; and Genentech, Inc.